KRYSTAL TUBBS: Open Payments
NPI 1114512480 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,227 in 67 payments from 13 companies in 2025. Trend: 2023 $718 · 2024 $871 · 2025 $1,227
Food & beverage: $1,227
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $303 |
| Ardelyx, Inc. | 12 | $232 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $171 |
| QOL Medical, LLC | 5 | $123 |
| Janssen Biotech, Inc. | 5 | $94 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $91 |
| Gilead Sciences, Inc. | 4 | $66 |
| PFIZER INC. | 3 | $53 |
| Madrigal Pharmaceuticals | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
Products named: IBSRELA, ENTYVIO, Sucraid, CREON, TREMFYA, XIFAXAN, RINVOQ, XELJANZ.
Industry payments across AL — which companies pay providers there.
